NCT06168110

Brief Summary

The main objective of this study is to determine the effectiveness of transcutaneous electrical nerve stimulation (TENS) treatment on pain and quality of life in mastalgia, which treatment has not yet reached a consensus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 13, 2023

Completed
Last Updated

December 13, 2023

Status Verified

December 1, 2023

Enrollment Period

9 months

First QC Date

November 10, 2023

Last Update Submit

December 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain intensity

    The Breast Pain Questionnaire (BPQ), derived from the McGill Pain Questionnaire, was used to assess breast pain intensity. It is a tool that aims to evaluate the severity, pattern, location, duration and frequency of breast pain. It is calculated on the basis of Visual analog scale (VAS) and present pain intensity (PPI) scores in addition to sensory and affective component scores. Regarding the final total BPQ scores, patients' pain severity classified as mild (0-100), moderate (100-200), and severe (\>200)

    Before and 10 days after treatment

Secondary Outcomes (1)

  • Quality of life

    Before and 10 days after treatment

Study Arms (2)

TENS

ACTIVE COMPARATOR
Device: TENS

Sham TENS

SHAM COMPARATOR
Device: TENS

Interventions

TENSDEVICE

Transcutaneous electrical nerve stimulation (TENS) is a non-invasive treatment method widely used for pain control

Sham TENSTENS

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with mastalgia between 18 and 70 yrs old

You may not qualify if:

  • Previous or new diagnosis of diseases that may cause extramammary mastalgia (history of previous breast surgery; inflammatory and/or tumoral breast or chest disorders such as mastitis, fibrocystic breasts, breast cancer or chest malignancies etc.)
  • Having with conditions that might prevent TENS application (pacemaker, metal prosthesis, epilepsy, etc.)
  • Being unable or insufficient to fill the questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Universityt School of Medicine

Ankara, 06450, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Mastodynia

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Aysun Genç, Assoc Prof

    Ankara University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD Professor, Director

Study Record Dates

First Submitted

November 10, 2023

First Posted

December 13, 2023

Study Start

February 1, 2020

Primary Completion

November 1, 2020

Study Completion

January 1, 2023

Last Updated

December 13, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations